# AZD0530 in Treating Patients With Recurrent Locally Advanced or Metastatic Soft Tissue Sarcoma

> **NCT00659360** · PHASE2 · COMPLETED · sponsor: **National Cancer Institute (NCI)** · enrollment: 17 (actual)

## Conditions studied

- Adult Fibrosarcoma
- Adult Leiomyosarcoma
- Adult Liposarcoma
- Adult Malignant Fibrous Histiocytoma
- Adult Rhabdomyosarcoma
- Dermatofibrosarcoma Protuberans
- Endometrial Stromal Sarcoma
- Recurrent Adult Soft Tissue Sarcoma
- Recurrent Uterine Sarcoma
- Stage III Adult Soft Tissue Sarcoma
- Stage III Uterine Sarcoma
- Stage IV Adult Soft Tissue Sarcoma
- Stage IV Uterine Sarcoma
- Uterine Carcinosarcoma
- Uterine Leiomyosarcoma

## Interventions

- **DRUG:** saracatinib

## Key facts

- **NCT ID:** NCT00659360
- **Lead sponsor:** National Cancer Institute (NCI)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-02
- **Primary completion:** 2009-01
- **Final completion:** 2012-11
- **Target enrollment:** 17 (ACTUAL)
- **Last updated:** 2018-06-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00659360

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00659360, "AZD0530 in Treating Patients With Recurrent Locally Advanced or Metastatic Soft Tissue Sarcoma". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00659360. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*